Monitoring Tumor Glucose Utilization by Positron Emission Tomography for the Prediction of Treatment Response to Epidermal Growth Factor Receptor Kinase InhibitorsHelen C. Su, Wolfgang Weber, Claudia Bodenstein et al.|Clinical Cancer Research|2006Cited by 204
Evaluation of [18F]gefitinib as a molecular imaging probe for the assessment of the epidermal growth factor receptor status in malignant tumorsHelen C. Su, Wolfgang Weber, Yann Seimbille et al.|European Journal of Nuclear Medicine and Molecular Imaging|2008Cited by 106
Fluorine‐18 labeling of 6,7‐disubstituted anilinoquinazoline derivatives for positron emission tomography (PET) imaging of tyrosine kinase receptors: synthesis of <sup>18</sup>F‐Iressa and related molecular probesYann Seimbille, Daniel Silverman, Michael E. Phelps et al.|Journal of Labelled Compounds and Radiopharmaceuticals|2005Cited by 48
Highlight selection of radiochemistry and radiopharmacy developments by editorial boardSarah Spreckelmeyer, Jan Rijn Zeevaart, Jeroen J. M. A. Hendrikx et al.|EJNMMI Radiopharmacy and Chemistry|2025Cited by 1
Correction: Highlight selection of radiochemistry and radiopharmacy developments by editorial boardSarah Spreckelmeyer, Jan Rijn Zeevaart, Jean N. DaSilva et al.|EJNMMI Radiopharmacy and Chemistry|2025Cited by 0